Related Experiment Video

Updated: Aug 23, 2026

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses
06:02

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

Published on: February 23, 2024

National, state, and urban area vaccination coverage among children aged 19-35 months--United States, 2003

    MMWR. Morbidity and Mortality Weekly Report
    |July 30, 2004
    PubMed

    Insights

    The 2003 National Immunization Survey (NIS) shows increased vaccine coverage for children, including varicella and pneumococcal vaccines. However, significant geographic disparities in vaccination rates persist, requiring ongoing public health efforts.

    Area of Science:

    • Pediatric Public Health
    • Immunization Policy
    • Epidemiology

    Background:

    • Maintaining high childhood vaccination coverage is a critical public health challenge in the US.
    • The National Immunization Survey (NIS) monitors vaccination rates in children aged 19-35 months across states and urban areas.

    Purpose of the Study:

    • To summarize the 2003 National Immunization Survey (NIS) findings on vaccination coverage among young children.
    • To identify trends and geographic variations in vaccine uptake.

    Main Methods:

    • The National Immunization Survey (NIS) collected vaccination data from a representative sample of children aged 19-35 months.
    • Data analysis focused on coverage rates for individual vaccines and adherence to recommended schedules.

    Main Results:

    • Nationwide coverage increased for varicella vaccine (VAR) and pneumococcal conjugate vaccine (PCV).
    • Overall vaccination coverage reached its highest recorded level.
    • Significant geographic variability in coverage rates persisted among states and urban areas.

    Conclusions:

    • While overall vaccination coverage is improving, sustained public health efforts are necessary to maintain these gains.
    • Addressing and reducing geographic disparities in vaccination coverage remains a priority.

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Vaccines01:21

    Vaccines

    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
    Poliomyelitis01:17

    Poliomyelitis

    Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
    Development of Immunocompetence01:22

    Development of Immunocompetence

    The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
    The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
    Subsequent T...